Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperhomocysteinemia and thrombosis.

S C Guba1, V Fonseca, L M Fink

  • 1Department of Medicine, University of Arkansas for Medical Sciences and the Little Rock VAMC, USA. scguba@ibm.net

Seminars in Thrombosis and Hemostasis
|August 12, 1999
PubMed
Summary

Homocysteine is a risk factor for vascular occlusive disease (VOD). While the link is clear in severe cases, mild to moderate hyperhomocysteinemia

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Genomic and epidemiological monitoring of yellow fever virus transmission potential.

Science (New York, N.Y.)·2018
Same author

Birthweight and cardiometabolic risk patterns in multiracial children.

International journal of obesity (2005)·2017
Same author

Tourism as a driver of conflicts and changes in fisheries value chains in Marine Protected Areas.

Journal of environmental management·2017
Same author

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme.

Diabetes, obesity & metabolism·2015

Area of Science:

  • Cardiovascular Science
  • Thrombosis Research
  • Metabolic Disease

Background:

  • Homocysteine is an independent risk factor for atherosclerotic and thrombotic diseases.
  • Hyperhomocysteinemia is associated with both arterial and veno-occlusive diseases (VOD).
  • The association is clear in homocystinuria but controversial in mild to moderate hyperhomocysteinemia due to multiple etiologies.

Purpose of the Study:

  • To review studies supporting or refuting homocysteine as an independent risk factor for VOD.
  • To explore the complexities in studying the homocysteine-VOD relationship.
  • To highlight ongoing research in homocysteine and thrombosis.

Main Methods:

  • Review of existing scientific literature.
  • Analysis of studies investigating the link between homocysteine levels and vascular occlusive disease.
  • Examination of factors influencing homocysteine levels and VOD etiology.

Main Results:

  • Clear association between homocysteine and VOD in severe hyperhomocysteinemia (homocystinuria).
  • Controversy persists regarding the role of mild to moderate hyperhomocysteinemia in VOD.
  • Multiple contributing factors complicate controlled studies.

Conclusions:

  • The relationship between homocysteine and VOD is complex and multifactorial.
  • Further research is needed to clarify homocysteine's role as an independent risk factor.
  • Homocysteine and thrombosis research remains an active and evolving field.

Related Experiment Videos